Update in Asthma and Airway Inflammation 2018

Am J Respir Crit Care Med. 2019 Jul 1;200(1):14-19. doi: 10.1164/rccm.201902-0321UP.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Asthmatic Agents / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma / diagnostic imaging
  • Asthma / drug therapy
  • Asthma / epidemiology
  • Asthma / immunology*
  • Disease Models, Animal
  • Environmental Exposure / statistics & numerical data*
  • Female
  • Humans
  • In Vitro Techniques
  • Inflammation*
  • Obesity / epidemiology
  • Obesity / immunology
  • Omalizumab / therapeutic use
  • Particulate Matter
  • Pneumonia, Mycoplasma / epidemiology
  • Pneumonia, Mycoplasma / immunology
  • Pregnancy
  • Prenatal Exposure Delayed Effects / epidemiology
  • Prenatal Exposure Delayed Effects / immunology
  • Respiratory Hypersensitivity / drug therapy
  • Respiratory Hypersensitivity / epidemiology
  • Respiratory Hypersensitivity / immunology
  • Respiratory Mucosa
  • Sugar-Sweetened Beverages
  • Vaping

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • Particulate Matter
  • Omalizumab
  • reslizumab
  • dupilumab
  • benralizumab
  • mepolizumab